Literature DB >> 1692035

Relationship of one form of human histamine-releasing factor to connective tissue activating peptide-III.

M L Baeza1, S R Reddigari, D Kornfeld, N Ramani, E M Smith, P A Hossler, T Fischer, C W Castor, P G Gorevic, A P Kaplan.   

Abstract

We have previously reported purification of three forms of histamine-releasing factors (HRFs) from mixtures of streptokinase-streptodornase stimulated human mononuclear cells and platelets with apparent molecular masses of 10-12, 15-17, and 40-41 kD (1989. J. Clin. Invest. 83:1204-1210). We have also prepared mouse MAbs against the 10-12-kD HRF (1989. J. Allergy Clin. Immunol. 83:281). Affinity-purified 10-12-kD HRF appears as a broad band upon polyacrylamide gel electrophoresis in the presence of SDS. We determined the NH2-terminal amino acid sequence of the top and bottom halves of this broad band. Sequence analysis revealed striking homology between this HRF and connective tissue activating peptide-III (CTAP-III), a platelet-derived 8-10-kD protein known to cause mitogenesis and extracellular matrix formation in fibroblast cultures. 19 of 21 NH2-terminal residues in the top half of the HRF band were identical to the NH2-terminal sequence of CTAP-III. 20 of 21 NH2-terminal residues in the bottom half were identical to the NH2-terminal sequence of neutrophil-activating peptide-2, which is derived from CTAP-III by proteolytic cleavage between residues 15 and 16. Purified CTAP-III also released histamine from basophils. Rabbit antiserum raised against either native or recombinant CTAP-III recognized affinity-purified HRF in immunodot blot assays, and MAb against HRF recognized CTAP-III in both dot blot and microtiter plate based immunoassays. These data demonstrate the first structural, functional, and immunologic relationship between one form of human HRF and a previously described cell product.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1692035      PMCID: PMC296599          DOI: 10.1172/JCI114598

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  33 in total

1.  Connective tissue activating peptides.

Authors:  C W Castor; A R Cabral
Journal:  Methods Enzymol       Date:  1988       Impact factor: 1.600

2.  Cellular origin of histamine-releasing factor produced by peripheral blood mononuclear cells.

Authors:  R Alam; P A Forsythe; M A Lett-Brown; J A Grant
Journal:  J Immunol       Date:  1989-06-01       Impact factor: 5.422

3.  Comparative effect of recombinant IL-1, -2, -3, -4, and -6, IFN-gamma, granulocyte-macrophage-colony-stimulating factor, tumor necrosis factor-alpha, and histamine-releasing factors on the secretion of histamine from basophils.

Authors:  R Alam; J B Welter; P A Forsythe; M A Lett-Brown; J A Grant
Journal:  J Immunol       Date:  1989-05-15       Impact factor: 5.422

4.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

5.  Transformation by Rous sarcoma virus induces a novel gene with homology to a mitogenic platelet protein.

Authors:  S Sugano; M Y Stoeckle; H Hanafusa
Journal:  Cell       Date:  1987-05-08       Impact factor: 41.582

6.  Neutrophil attractant/activation protein-1 (NAP-1) causes human basophil histamine release.

Authors:  M V White; T Yoshimura; W Hook; M A Kaliner; E J Leonard
Journal:  Immunol Lett       Date:  1989-08       Impact factor: 3.685

7.  Platelet glycoproteins IIb and IIIa associated with blood monocytes are derived from platelets.

Authors:  R B Levene; E M Rabellino
Journal:  Blood       Date:  1986-01       Impact factor: 22.113

8.  Constitutive overexpression of a growth-regulated gene in transformed Chinese hamster and human cells.

Authors:  A Anisowicz; L Bardwell; R Sager
Journal:  Proc Natl Acad Sci U S A       Date:  1987-10       Impact factor: 11.205

9.  The neutrophil-activating peptide NAF/NAP-1 induces histamine and leukotriene release by interleukin 3-primed basophils.

Authors:  C A Dahinden; Y Kurimoto; A L De Weck; I Lindley; B Dewald; M Baggiolini
Journal:  J Exp Med       Date:  1989-11-01       Impact factor: 14.307

10.  Effects of the neutrophil-activating peptide NAP-2, platelet basic protein, connective tissue-activating peptide III and platelet factor 4 on human neutrophils.

Authors:  A Walz; B Dewald; V von Tscharner; M Baggiolini
Journal:  J Exp Med       Date:  1989-11-01       Impact factor: 14.307

View more
  6 in total

Review 1.  Mast cells. Receptors, secretagogues, and signaling.

Authors:  Bhavya B Sharma; John R Apgar; Fu-Tong Liu
Journal:  Clin Rev Allergy Immunol       Date:  2002-04       Impact factor: 8.667

Review 2.  IgE-dependent histamine-releasing factors.

Authors:  H A Sampson; S M MacDonald
Journal:  Springer Semin Immunopathol       Date:  1993

3.  Characterization of histamine-releasing activity: role of cytokines and IgE heterogeneity.

Authors:  T N Liao; K H Hsieh
Journal:  J Clin Immunol       Date:  1992-07       Impact factor: 8.317

4.  Monocyte chemotactic and activating factor is a potent histamine-releasing factor for basophils.

Authors:  R Alam; M A Lett-Brown; P A Forsythe; D J Anderson-Walters; C Kenamore; C Kormos; J A Grant
Journal:  J Clin Invest       Date:  1992-03       Impact factor: 14.808

5.  Macrophage inflammatory protein-1 alpha activates basophils and mast cells.

Authors:  R Alam; P A Forsythe; S Stafford; M A Lett-Brown; J A Grant
Journal:  J Exp Med       Date:  1992-09-01       Impact factor: 14.307

6.  Monocyte chemotactic and activating factor is a potent histamine-releasing factor for human basophils.

Authors:  P Kuna; S R Reddigari; D Rucinski; J J Oppenheim; A P Kaplan
Journal:  J Exp Med       Date:  1992-02-01       Impact factor: 14.307

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.